Autoimmune diseases (ADs) impose substantial health and financial burdens in the United States and in many parts of the world. Women are disproportionately affected by many of these disorders, which often contribute to lifelong disabilities. While the number of patients with some ADs appears to be rising, the complexities of conducting epidemiological studies prevent a thorough understanding of the prevalence and incidence of these various conditions. Research on environmental influences of these illnesses is limited, although they are generally hypothesized to result from the interaction of environmental agents in genetically susceptible individuals. Further, there is little known regarding the role of sex and gender in the environmentally influenced mechanisms leading to the development of AD. To address these issues, particularly the roles of environment and sex and gender in ADs and the factors that contribute to the rise in ADs, the Society for Women's Health Research convened an interdisciplinary roundtable of experts from academia, medicine, and government agencies to share their expertise, address knowledge gaps in research, and propose future research recommendations.
Get full access to this article
View all access options for this article.
References
1.
MillerFW, AlfredssonL, CostenbaderKHet al.Epidemiology of environmental exposures and human autoimmune diseases: Findings from a National Institute of Environmental Health Sciences expert panel workshop. J Autoimmun, 2012; 39:259–271.
2.
FairweatherD, Frisancho-KissS, RoseNR. Sex differences in autoimmune disease from a pathological perspective. Am J Pathol, 2008; 173:600–609.
3.
JacobsonDL, GangeSJ, RoseNR, GrahamNM. Epidemiology and estimated population burden of selected autoimmune diseases in the United States. Clin Immunol Immunopathol., 1997; 84:223–243.
4.
CooperGS, BynumML, SomersEC. Recent insights in the epidemiology of autoimmune diseases: Improved prevalence estimates and understanding of clustering of diseases. J Autoimmun., 2009; 33:197–207.
5.
WalshSJ, RauLM. Autoimmune diseases: a leading cause of death among young and middle-aged women in the United States. Am J Public Health, 2000; 90:1463–1466.
6.
NIH Autoimmune Diseases Coordinating Committee (ADCC). Progress in autoimmune diseases research: Report to Congress. Washington, DC: U.S. Department of Health and Human Services, 2005.
7.
CostenbaderKH, GayS, Alarcon-RiquelmeME, IaccarinoL, DoriaA. Genes, epigenetic regulation and environmental factors: Which is the most relevant in developing autoimmune diseases?Autoimmun Rev, 2012; 11:604–609.
8.
HewagamaA, RichardsonB. The genetics and epigenetics of autoimmune diseases. J Autoimmun, 2009; 33:3–11.
SelmiC, LeungPS, SherrDHet al.Mechanisms of environmental influence on human autoimmunity: a national institute of environmental health sciences expert panel workshop. J Autoimmun, 2012; 39:272–284.
11.
GermolecD, KonoDH, PfauJC, PollardKM. Animal models used to examine the role of the environment in the development of autoimmune disease: Findings from an NIEHS expert panel workshop. J Autoimmun, 2012; 39:285–293.
12.
UramotoKM, MichetCJJr., ThumbooJ, SunkuJ, O'FallonWM, GabrielSE. Trends in the incidence and mortality of systemic lupus erythematosus, 1950–1992. Arthritis Rheum, 1999; 42:46–50.
13.
TEDDY Study Group. The environmental determinants of diabetes in the young (TEDDY) study. Ann N Y Acad Sci, 2008; 1150:1–13.
14.
MyasoedovaE, CrowsonCS, KremersHM, TherneauTM, GabrielSE. Is the incidence of rheumatoid arthritis rising?: Results from Olmsted County, Minnesota, 1955–2007. Arthritis Rheum, 2010; 62:1576–1582.
15.
PollardKM. Gender differences in autoimmunity associated with exposure to environmental factors. J Autoimmun, 2012; 38:J177–186.
16.
KarlsonEW, ChangSC, CuiJet al.Gene-environment interaction between HLA-DRB1 shared epitope and heavy cigarette smoking in predicting incident rheumatoid arthritis. Ann Rheum Dis, 2010; 69:54–60.
17.
CooperGS, GilbertKM, GreidingerELet al.Recent advances and opportunities in research on lupus: Environmental influences and mechanisms of disease. Environ Health Perspect, 2008; 116:695–702.
18.
LleoA, BattezzatiPM, SelmiC, GershwinME, PoddaM. Is autoimmunity a matter of sex?Autoimmun Rev, 2008; 7:626–630.
19.
McNamaraDM, StarlingRC, CooperLTet al.Clinical and demographic predictors of outcomes in recent onset dilated cardiomyopathy: Results of the IMAC (Intervention in myocarditis and acute cardiomyopathy)-2 study. J Am Coll Cardiol, 2011; 58:1112–1118.
20.
McCombePA, GreerJM, MackayIR. Sexual dimorphism in autoimmune disease. Curr Mol Med, 2009; 9:1058–1079.
21.
Zandman-GoddardG, PeevaE, ShoenfeldY. Gender and autoimmunity. Autoimmun Rev, 2007; 6:366–372.
22.
Lupus Foundation of America. How lupus differs in men. http://www.lupus.org/webmodules/webarticlesnet/templates/new_about.aspx?articleid=405&zoneid=2.
23.
NewlandPK, NaismithRT, UllioneM. The impact of pain and other symptoms on quality of life in women with relapsing-remitting multiple sclerosis. J Neurosci Nurs, 2009; 41:322–328.
24.
GuoZN, HeSY, ZhangHL, WuJ, YangY. Multiple sclerosis and sexual dysfunction. Asian J Androl, 2012; 14:530–535.
25.
LateefA, PetriM. Unmet medical needs in systemic lupus erythematosus. Arthritis Res Ther, 2012; 14,Suppl 4:S4.
26.
MillerFW. Environmental agents and autoimmune diseases. Adv Exp Med Biol, 2011; 711:61–81.
27.
FernandoMM, StevensCR, WalshECet al.Defining the role of the MHC in autoimmunity: A review and pooled analysis. PLoS Genet, 2008; 4:e1000024.
28.
OkadaY, YamadaR, SuzukiAet al.Contribution of a haplotype in the HLA region to anti-cyclic citrullinated peptide antibody positivity in rheumatoid arthritis, independently of HLA-DRB1. Arthritis Rheum, 2009; 60:3582–3590.
29.
QuinteroOL, Amador-PatarroyoMJ, Montoya-OrtizG, Rojas-VillarragaA, AnayaJM. Autoimmune disease and gender: plausible mechanisms for the female predominance of autoimmunity. J Autoimmun, 2012; 38:J109–119.
30.
SuDL, LuZM, ShenMN, LiX, SunLY. Roles of pro- and anti-inflammatory cytokines in the pathogenesis of SLE. J Biomed Biotechnol, 2012; 2012:347141.
31.
ChoubeyD. DNA-responsive inflammasomes and their regulators in autoimmunity. Clin Immunol, 2012; 142:223–231.
32.
LateefA, PetriM. Hormone replacement and contraceptive therapy in autoimmune diseases. J Autoimmun, 2012; 38:J170–176.
33.
SatohM, ChanEK, HoLAet al.Prevalence and sociodemographic correlates of antinuclear antibodies in the United States. Arthritis Rheum, 2012; 64:2319–2327.
34.
EatonWW, RoseNR, KalaydjianA, PedersenMG, MortensenPB. Epidemiology of autoimmune diseases in Denmark. J Autoimmun, 2007; 29:1–9.
35.
PetoR, DarbyS, DeoH, SilcocksP, WhitleyE, DollR. Smoking, smoking cessation, and lung cancer in the UK since 1950: Combination of national statistics with two case-control studies. BMJ, 2000; 321:323–329.
36.
ParksCG, CooperGS, Nylander-FrenchLAet al.Occupational exposure to crystalline silica and risk of systemic lupus erythematosus: a population-based, case-control study in the southeastern United States. Arthritis Rheum, 2002; 46:1840–1850.
37.
GoldLS, WardMH, DosemeciM, De RoosAJ. Systemic autoimmune disease mortality and occupational exposures. Arthritis Rheum, 2007; 56:3189–3201.
38.
OlssonAR, SkoghT, AxelsonO, WingrenG. Occupations and exposures in the work environment as determinants for rheumatoid arthritis. Occup Environ Med, 2004; 61:233–238.
39.
KhuderSA, PeshimamAZ, AgraharamS. Environmental risk factors for rheumatoid arthritis. Rev Environ Health, 2002; 17:307–315.
40.
CobleJ, HoppinJA, EngelLet al.Prevalence of exposure to solvents, metals, grain dust, and other hazards among farmers in the Agricultural Health Study. J Expo Anal Environ Epidemiol, 2002; 12:418–426.
41.
ParksCG, WalittBT, PettingerMet al.Insecticide use and risk of rheumatoid arthritis and systemic lupus erythematosus in the Women's Health Initiative Observational Study. Arthritis Care Res (Hoboken), 2011; 63:184–194.
42.
ParksCG, D'AloisioAA, DeRooLAet al.Childhood socioeconomic factors and perinatal characteristics influence development of rheumatoid arthritis in adulthood. Ann Rheum Dis, 2013; 72:350–356.
RozzoSJ, AllardJD, ChoubeyDet al.Evidence for an interferon-inducible gene, Ifi202, in the susceptibility to systemic lupus. Immunity, 2001; 15:435–443.
45.
JorgensenTN, RoperE, ThurmanJM, MarrackP, KotzinBL. Type I interferon signaling is involved in the spontaneous development of lupus-like disease in B6.Nba2 and (B6.Nba2 x NZW)F(1) mice. Genes Immun, 2007; 8:653–662.
46.
PanchanathanR, ShenH, BuppMG, GouldKA, ChoubeyD. Female and male sex hormones differentially regulate expression of Ifi202, an interferon-inducible lupus susceptibility gene within the Nba2 interval. J Immunol, 2009; 183:7031–7038.
47.
PanchanathanR, DuanX, ArumugamM, ShenH, LiuH, ChoubeyD. Cell type and gender-dependent differential regulation of the p202 and Aim2 proteins: implications for the regulation of innate immune responses in SLE. Mol Immunol, 2011; 49:273–280.
48.
ChoubeyD, PanchanathanR, DuanX, LiuH. Emerging roles for the interferon-inducible p200-family proteins in sex bias in systemic lupus erythematosus. J Interferon Cytokine Res, 2011; 31:893–906.
49.
PanchanathanR, LiuH, FangCM, EricksonLD, PithaPM, ChoubeyD. Distinct regulation of murine lupus susceptibility genes by the IRF5/Blimp-1 axis. J Immunol, 2012; 188:270–278.
50.
ShenH, PanchanathanR, RajaveluP, DuanX, GouldKA, ChoubeyD. Gender-dependent expression of murine Irf5 gene: implications for sex bias in autoimmunity. J Mol Cell Biol, 2010; 2:284–290.
PatelDR, RichardsonBC. Dissecting complex epigenetic alterations in human lupus. Arthritis Res Ther, 2013; 15:201.
53.
HewagamaA, GorelikG, PatelDet al.Overexpression of X-Linked genes in T cells from women with lupus. J Autoimmun, 2013; 41:60–71.
54.
SawalhaAH, WangL, NadigAet al.Sex-specific differences in the relationship between genetic susceptibility, T cell DNA demethylation and lupus flare severity. J Autoimmun, 2012; 38:J216–222.
55.
StanczykJ, PedrioliDM, BrentanoFet al.Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum, 2008; 58:1001–1009.
56.
PauleyKM, SatohM, ChanAL, BubbMR, ReevesWH, ChanEK. Upregulated miR-146a expression in peripheral blood mononuclear cells from rheumatoid arthritis patients. Arthritis Res Ther, 2008; 10:R101.
57.
DaiR, AhmedSA. MicroRNA, a new paradigm for understanding immunoregulation, inflammation, and autoimmune diseases. Transl Res, 2011; 157:163–179.
58.
CeribelliA, YaoB, Dominguez-GutierrezPR, NahidMA, SatohM, ChanEK. MicroRNAs in systemic rheumatic diseases. Arthritis Res Ther, 2011; 13:229.
DaiR, ZhangY, KhanDet al.Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One., 2010; 5:e14302.
61.
DaiR, PhillipsRA, ZhangY, KhanD, CrastaO, AhmedSA. Suppression of LPS-induced interferon-gamma and nitric oxide in splenic lymphocytes by select estrogen-regulated microRNAs: A novel mechanism of immune modulation. Blood, 2008; 112:4591–4597.
62.
SinghNP, SinghUP, GuanH, NagarkattiP, NagarkattiM. Prenatal exposure to TCDD triggers significant modulation of microRNA expression profile in the thymus that affects consequent gene expression. PLoS One, 2012; 7:e45054.
63.
FisherMT, NagarkattiM, NagarkattiPS. 2,3,7,8-tetrachlorodibenzo-p-dioxin enhances negative selection of T cells in the thymus but allows autoreactive T cells to escape deletion and migrate to the periphery. Mol Pharmacol, 2005; 67:327–335.
64.
SinghNP, SinghUP, SinghB, PriceRL, NagarkattiM, NagarkattiPS. Activation of aryl hydrocarbon receptor (AhR) leads to reciprocal epigenetic regulation of FoxP3 and IL-17 expression and amelioration of experimental colitis. PLoS One, 2011; 6:e23522.
65.
GriffinJM, GilbertKM, LampsLW, PumfordNR. CD4(+) T-cell activation and induction of autoimmune hepatitis following trichloroethylene treatment in MRL+/+ mice. Toxicol Sci, 2000; 57:345–352.
66.
Fernandes AzevedoB, Barros FurieriL, PecanhaFMet al.Toxic effects of mercury on the cardiovascular and central nervous systems. J Biomed Biotechnol, 2012; 2012:949048.
67.
CaldasED, JardimAN. Exposure to toxic chemicals in the diet: Is the Brazilian population at risk?J Expo Sci Environ Epidemiol, 2011; 22:1–15.
EislerR. Mercury hazards from gold mining to humans, plants, and animals. Rev Environ Contam Toxicol, 2004; 181:139–198.
70.
GardnerRM, NylandJF, SilvaIA, VenturaAM, de SouzaJM, SilbergeldEK. Mercury exposure, serum antinuclear/antinucleolar antibodies, and serum cytokine levels in mining populations in Amazonian Brazil: A cross-sectional study. Environ Res, 2010; 110:345–354.
